{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:29:48Z","timestamp":1758709788683,"version":"3.37.3"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[1992,9,1]],"date-time":"1992-09-01T00:00:00Z","timestamp":715305600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6,28]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The role of natural killer (NK) cells and their inducible counterparts, lymphokine-activated killer (LAK) cells in AIDS with regard to HIV-1 viral immunosurveillance and the control of secondary opportunistic disease has yet to be established. In this study, we have demonstrated that LAK cells derived from all HIV-1+ groups showed striking increases in their capacity to lyse HIV-1-infected U-937 cells relative to their uninfected U-937 counterparts. Surprisingly, similarly derived LAK cells from healthy seronegative controls showed no differences in their lysis of HIV-1-infected versus uninfected U-937 cells. The differential ability of LAK effectors from seropositive donors to lyse HIV-1-infected targets was demonstrable using a number of U-937 subclones and their HIV-1-infected counterparts. Again, no differences in LAK cell-mediated lysis of HIV-1-infected and uninfected U-937 subclones were observed in seronegative individuals. Our findings that HIV-1+ individuals show selective expansion of non-MHC restricted. HIV-1-directed cytotoxic LAK cells indicate that natural immunity may indeed play a role in HIV-1 viral immunosurveillance.<\/jats:p>","DOI":"10.1111\/j.1365-2249.1992.tb06962.x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T14:08:17Z","timestamp":1281622097000},"page":"356-361","source":"Crossref","is-referenced-by-count":7,"title":["Increased LAK activity against HIV-infected cell lines in HIV-1+ individuals"],"prefix":"10.1093","volume":"89","author":[{"given":"C","family":"GRYLLIS","sequence":"first","affiliation":[{"name":"McGill AIDS Centre"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A","family":"WAINBERG","sequence":"additional","affiliation":[{"name":"McGill AIDS Centre"},{"name":"the Lady Davis Institute of the Jewish General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z","family":"BENTWICH","sequence":"additional","affiliation":[{"name":"Kaplan Hospital, Rehovot, Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"GORNITSKY","sequence":"additional","affiliation":[{"name":"Department of Dentistry, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B G","family":"BRENNER","sequence":"additional","affiliation":[{"name":"McGill AIDS Centre"},{"name":"Department of Experimental Surgery, Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"2022011618483414000_b1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-114-8-678","article-title":"Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection","volume":"114","author":"Fauci","year":"1991","journal-title":"Ann Int Med"},{"key":"2022011618483414000_b2","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv Immunol"},{"key":"2022011618483414000_b3","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","article-title":"Biology and clinical relevance of natural killer cells","volume":"76","author":"Robertson","year":"1991","journal-title":"Blood"},{"key":"2022011618483414000_b4","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0065-2776(08)60845-7","article-title":"Characterization of functional surface structures on human natural killer cells","volume":"42","author":"Ritz","year":"1988","journal-title":"Adv Immunol"},{"key":"2022011618483414000_b5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/jlb.46.1.75","article-title":"Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases","volume":"46","author":"Brenner","year":"1989","journal-title":"J Leucocyte Biol"},{"key":"2022011618483414000_b6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/jlb.50.6.628","article-title":"The role of antibody-dependent cellular cytotoxicity and lymphokine-activated killer cells in AIDS and related diseases","volume":"50","author":"Brenner","year":"1991","journal-title":"J Leucocyte Biol"},{"key":"2022011618483414000_b7","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.4049\/jimmunol.144.9.3375","article-title":"Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects","volume":"144","author":"Tyler","year":"1990","journal-title":"J Immunol"},{"key":"2022011618483414000_b8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4049\/jimmunol.139.1.55","article-title":"Mechanism of defective NK cell activity in patients with AIDS and AIDS-related complex. II Normal ADCC mediated by effector cells defective in NK cytotoxicity","volume":"139","author":"Katz","year":"1987","journal-title":"J Immunol"},{"key":"2022011618483414000_b9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.4049\/jimmunol.140.8.2565","article-title":"Mechanism of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin","volume":"140","author":"Sirianni","year":"1988","journal-title":"J Immunol"},{"key":"2022011618483414000_b10","first-page":"969","article-title":"Differential effects of chemotherapy-induced and HIV-1 induced immunocompromise on NK and LAK activities using breast cancer and HIV-1+ patient populations","volume":"11","author":"Brenner","year":"1991","journal-title":"Anticancer Res"},{"key":"2022011618483414000_b11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1089\/aid.1988.4.121","article-title":"Selective depletion of low-density CD8+, CD16+ lymphocytes during HIV infection","volume":"4","author":"Vuillier","year":"1988","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011618483414000_b12","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00002030-199006000-00001","article-title":"Application of flow cytometry to the study of HIV function","volume":"4","author":"Landay","year":"1990","journal-title":"AIDS"},{"key":"2022011618483414000_b13","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(88)91713-8","article-title":"Cellular anti-gp120 cytolytic reactivities in HIV-1+ individuals","volume":"i","author":"Weinhold","year":"1988","journal-title":"Lancet"},{"key":"2022011618483414000_b14","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1128\/jvi.63.5.2270-2277.1989","article-title":"Human immunodeficiency virus-specific cytotoxic responses of seropositive individuals. Distinct types of effector cells mediate killing of targets expressing gag and env proteins","volume":"63","author":"Rivi\u00e8re","year":"1989","journal-title":"J Virol"},{"key":"2022011618483414000_b15","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.4049\/jimmunol.142.9.3091","article-title":"HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection","volume":"142","author":"Weinhold","year":"1989","journal-title":"J Immunol"},{"key":"2022011618483414000_b16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/BF02173452","article-title":"Intorleukin-2 in the treatment of HIV disease","volume":"2","author":"Schwartz","year":"1990","journal-title":"Biotherapy"},{"key":"2022011618483414000_b17","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1093\/jnci\/80.13.999","article-title":"Human natural lymphocyte effector cells. Definition, analysis of activity and clinical effectiveness","volume":"80","author":"Ortaldo","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"2022011618483414000_b18","first-page":"267","article-title":"Human lymphokine-activated killer ceils (LAK cells) as a potential immunotherapeutic modality","volume":"565","author":"Grimm","year":"1986","journal-title":"Biochim Biophys Acta"},{"key":"2022011618483414000_b19","first-page":"291","article-title":"Human lymphokine-activated killer cells. Further characterization of the precursor and effector cell","volume":"6","author":"Skibber","year":"1987","journal-title":"Nat Immun Cell Growth Regul"},{"key":"2022011618483414000_b20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1084\/jem.164.4.1193","article-title":"Lymphokine-activated killer cells. Analysis of progenitors and effectors","volume":"164","author":"Ortaldo","year":"1986","journal-title":"J Exp Med"},{"key":"2022011618483414000_b21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1084\/jem.164.3.814","article-title":"Dissection of the lymphokine-activated phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis","volume":"164","author":"Phillips","year":"1986","journal-title":"J Exp Med"},{"key":"2022011618483414000_b22","first-page":"3680","article-title":"Lymphokine-activated killer activity induced by in vivo interlcukin-2 therapy: predominant role for lymphocytes with increased expression of CD2 and Leu 19 antigens but negative expression of CD16 antigens","volume":"49","author":"Weil-Hillman","year":"1989","journal-title":"Cancer Res"},{"key":"2022011618483414000_b23","first-page":"5230","article-title":"Differences between in vivo and in vitro activation of cancer patient lymphocytes by recombinant interleukin-2: possible role of lymphokine-activated killer cell infusion in the in vivo induced activation","volume":"49","author":"Gambacorti-Passerini","year":"1989","journal-title":"Cancer Res"},{"key":"2022011618483414000_b24","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4049\/jimmunol.140.4.1335","article-title":"In vivo effects of recombinant IL 2. I. Isolation of circulating Leu19+ lymphokine-activated killer effector cells from cancer patients receiving recombinant IL-2","volume":"140","author":"McMannis","year":"1988","journal-title":"J Immunol"},{"key":"2022011618483414000_b25","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1200\/JCO.1987.5.12.1933","article-title":"In vivo and in vitro activation of natural killer cells in advanced cancer patients undergoing recombinant interleukin-2 and LAK cell therapy","volume":"5","author":"Phillips","year":"1987","journal-title":"J Clin Oncol"},{"key":"2022011618483414000_b26","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00002030-199012000-00004","article-title":"Diminution of inducible lymphokine-activated killer cell activity in individuals with AIDS-related disorders","volume":"4","author":"Gryllis","year":"1990","journal-title":"AIDS"},{"key":"2022011618483414000_b27","first-page":"334","article-title":"Classification system for human T-lymphotropic virus type III\/lymphadenopathy-associated virus infections","volume":"35","year":"1986","journal-title":"MMWR"},{"key":"2022011618483414000_b28","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/1097-0142(19860815)58:4<895::AID-CNCR2820580416>3.0.CO;2-A","article-title":"Peripheral blood natural killer cell activity in human breast cancer patients and its modulation by T cell growth factor and autologous plasma","volume":"58","author":"Brenner","year":"1986","journal-title":"Cancer"},{"key":"2022011618483414000_b29","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1128\/jvi.66.2.1183-1187.1992","article-title":"Differential susceptibilities of U-937 cell clones to infection by human immunodeficiency virus type I","volume":"66","author":"Boulerice","year":"1992","journal-title":"J Virol"},{"key":"2022011618483414000_b30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/infdis\/160.1.31","article-title":"Susceptibility to AZT of HIV-1 variants grown in Epstein\u2013Barr virus transformed B cell lines","volume":"160","author":"Tremblay","year":"1989","journal-title":"J Infect Dis"},{"key":"2022011618483414000_b31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/BF00915477","article-title":"Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX: The quantitation of natural killer cell activity","volume":"1","author":"Pross","year":"1981","journal-title":"J Clin Immunol"},{"key":"2022011618483414000_b32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0277-5379(88)90159-9","article-title":"The difference in surface phenotypes between cytotoxic lymphocytes induced in vivo by systemic administration of human recombinant interlcukin-2 and lymphokine-activated killer cells induced in vitro","volume":"24","author":"Ozaki","year":"1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"2022011618483414000_b33","first-page":"13","article-title":"Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mono-nuclear cells","volume":"7","author":"Kedar","year":"1988","journal-title":"Nat Immun Cell Growth Regul"},{"key":"2022011618483414000_b34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01669422","article-title":"Immunomodulatory effects of systemic low-dose recombinant interleukin-2 and lymphokine-activated killer cells in humans","volume":"30","author":"Eberlein","year":"1989","journal-title":"Cancer Immunol Immunother"},{"key":"2022011618483414000_b35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0090-1229(89)90007-X","article-title":"Lymphokine-activated killer cells in primary immunodeficiencies and acquired immunodeficiency syndrome","volume":"53","author":"Chin","year":"1989","journal-title":"Clin Immunol Immunopathol"},{"key":"2022011618483414000_b36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1365-2249.1990.tb08107.x","article-title":"Natural killer cell-mediated lysis of T cell lines chronically infected with HIV-1","volume":"79","author":"Bandyopadhyay","year":"1990","journal-title":"Clin Exp Immunol"},{"key":"2022011618483414000_b37","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1128\/jcm.27.1.41-48.1989","article-title":"Association of alpha interferon production and natural killer cell lysis of U937 cells infected with human immunodeficiency virus","volume":"27","author":"Rappocciolo","year":"1989","journal-title":"J Clin Microbiol"},{"key":"2022011618483414000_b38","doi-asserted-by":"crossref","first-page":"3619","DOI":"10.4049\/jimmunol.136.10.3619","article-title":"Analysis of effector mechanisms against HTLV-I and HTLV-III\/LAV infected lymphoid cells","volume":"136","author":"Ruscetti","year":"1986","journal-title":"J Immunol"},{"key":"2022011618483414000_b39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1089\/aid.1990.6.1011","article-title":"Cytotoxic activity against HIV-infected monocytes by recombinant interlcukin-2-activated natural killer cells","volume":"6","author":"Melder","year":"1990","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2022011618483414000_b40","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1128\/jvi.65.4.1812-1822.1991","article-title":"In vitro infection of natural killer cells with different human immunodeficiency virus type I isolates","volume":"65","author":"Chehimi","year":"1991","journal-title":"J Virology"},{"key":"2022011618483414000_b41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0046-8177(88)80200-4","article-title":"Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus","volume":"19","author":"Robinson","year":"1988","journal-title":"Hum Pathol"},{"key":"2022011618483414000_b42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002030-199003000-00001","article-title":"Cytotoxic lymphocytes against HIV","volume":"4","author":"Walker","year":"1990","journal-title":"AIDS"},{"key":"2022011618483414000_b43","first-page":"1049","article-title":"Cytotoxic T-cell recognition of HIV proteins and peptides","volume":"5","author":"Nixon","year":"1991","journal-title":"AIDS"},{"key":"2022011618483414000_b44","first-page":"184","article-title":"Natural and antibody-dependent cytotoxicity in different clinical stages of human immunodeficiency virus type 1 infection","volume":"75","author":"Ljunggren","year":"1989","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2249.1992.tb06962.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/89\/3\/356\/42212493\/j.1365-2249.1992.tb06962.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/89\/3\/356\/42212493\/j.1365-2249.1992.tb06962.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:09:39Z","timestamp":1740380979000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/89\/3\/356\/6488132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,9]]},"references-count":44,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2008,6,28]]},"published-print":{"date-parts":[[2008,6,28]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2249.1992.tb06962.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"type":"print","value":"0009-9104"},{"type":"electronic","value":"1365-2249"}],"subject":[],"published-other":{"date-parts":[[1992,9]]},"published":{"date-parts":[[1992,9]]}}}